Skip to main content
Signal8

Leahy Emer

SEC insider (Form 3/4/5 filer). CIK 0001875180. Director at INTENSITY THERAPEUTICS, INC. (INTS) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jul 16, 2026. Located in SHELTON, CT.

Companies Leahy Emer has filed insider reports for

  • INTENSITY THERAPEUTICS, INC. (INTS): Director
  • Pasithea Therapeutics Corp. (KTTA): Director
Leahy Emer profile photo

Leahy Emer

CIK: 0001875180

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

INTENSITY THERAPEUTICS, INC. logo
INTS

INTENSITY THERAPEUTICS, INC.

Director
Pasithea Therapeutics Corp. logo
KTTA

Pasithea Therapeutics Corp.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • INTENSITY THERAPEUTICS, INC. logo
    INTS

    INTENSITY THERAPEUTICS, INC.

    Jul 16, 2026
    Award

    Stock Option (right to buy Common Stock)

    Direct
    5.5K shares-
  • Pasithea Therapeutics Corp. logo
    KTTA

    Pasithea Therapeutics Corp.

    May 1, 2026
    Award

    Stock Option (right to buy)

    Direct
    152.8K shares-
  • Pasithea Therapeutics Corp. logo
    KTTA

    Pasithea Therapeutics Corp.

    Nov 28, 2025
    Award
    Direct
    33.3K shares at avg. $0.75$25K
  • Pasithea Therapeutics Corp. logo
    KTTA

    Pasithea Therapeutics Corp.

    Oct 24, 2025
    Award

    Stock Option (right to buy)

    Direct
    42.9K shares-
  • INTENSITY THERAPEUTICS, INC. logo
    INTS

    INTENSITY THERAPEUTICS, INC.

    May 2, 2025
    Award

    Stock Option (right to buy Common Stock)

    Direct
    50K shares-

1-5 of 5